Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

Confo Therapeutics has been awarded a EUR 1 million grant [...]

Skye Bioscience has reported topline results from its Phase 2a [...]

Analysis highlights potential for benefits far beyond obesity, signalling a [...]

Imperial College London Diabetes & Endocrine Centre (ICLDEC) has expanded [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]

Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]